BridgeMD
New treatment option for Schizophrenia
Official title Real-time fMRI Neurofeedback in Patients With Schizophrenia and Auditory Hallucinations
ClinicalTrials.gov ID: NCT05299749
What this study is testing
- What it's testing
- Neurofeedback intervention aimed to regulate the superior temporal gyrus (STG) activation and default mode network (DMN) connectivity as well as to reduce the auditory hallucinations (AH) schizophrenia patients with medication resistant AH.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 55
You may be able to join if
- patients diagnosed with SZ or schizoaffective disorder using DSM-5 criteria
- auditory hallucinations not responsive to pharmacology as determined by chart review and a clinical interview of SCID.
You likely can't join if
- neurologic illness
- major head trauma
- electroconvulsive therapy
- alcohol or drug dependence
- alcohol or drug abuse within the past five years
- verbal IQ below 70
The study team makes the final eligibility decision.
Where it's taking place
- Brockton, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brockton, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.